Hospitals in the US make the same kind of plausibility analysis when they consider experimental treatments, and Hirano's hospital in New York City would have had to apply for and receive approval to give Gard the nucleoside therapy under the US compassionate use framework.
Hospitals in the US make the same kind of plausibility analysis when they consider experimental treatmen. Presbyterian Hospital would have had to receive approval to give Gard the nucleoside therapy under the US compassionate-use framework.